KEGG   PATHWAY: hai05213
Entry
hai05213                    Pathway                                
Name
Endometrial cancer - Hipposideros armiger (great roundleaf bat)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
hai05213  Endometrial cancer
hai05213

Disease
H00026  Endometrial cancer
Organism
Hipposideros armiger (great roundleaf bat) [GN:hai]
Gene
109371340  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
109372681  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
109373414  [KO:K05691]
109373811  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
109374090  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
109374859  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
109375221  SOS2; son of sevenless homolog 2 [KO:K03099]
109375639  HRAS; GTPase HRas isoform X1 [KO:K02833]
109376531  ILK; integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
109376563  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
109376565  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
109377015  NRAS; GTPase NRas [KO:K07828]
109377341  CTNNB1; catenin beta-1 [KO:K02105]
109379436  EGF; pro-epidermal growth factor [KO:K04357]
109379461  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
109380327  AXIN2; axin-2 isoform X1 [KO:K04385]
109380800  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
109381083  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
109381238  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
109381302  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
109381899  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
109382484  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
109382635  TCF7; transcription factor 7 isoform X1 [KO:K02620]
109383211  MYC; myc proto-oncogene protein [KO:K04377]
109383688  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
109384256  BAD; bcl2-associated agonist of cell death [KO:K02158]
109384548  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
109384898  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
109384926  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
109385150  [KO:K02833]
109385200  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
109385252  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
109385353  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
109385471  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
109385803  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
109385875  PDPK1; 3-phosphoinositide-dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
109385878  [KO:K04456] [EC:2.7.11.1]
109385980  AXIN1; axin-1 isoform X1 [KO:K02157]
109387530  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109388365  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
109388396  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
109388626  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
109389264  KRAS; GTPase KRas isoform X1 [KO:K07827]
109389297  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
109389333  CDH1; cadherin-1 [KO:K05689]
109390202  DDB2; DNA damage-binding protein 2 [KO:K10140]
109390584  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
109390647  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
109391068  BAX; apoptosis regulator BAX [KO:K02159]
109391421  FOXO3; forkhead box protein O3 [KO:K09408]
109391522  APC; adenomatous polyposis coli protein [KO:K02085]
109392454  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
109393040  CTNNA1; catenin alpha-1 [KO:K05691]
109394108  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
109394672  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
109394900  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
109395605  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
109395865  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
109395991  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
hai04010  MAPK signaling pathway
hai04012  ErbB signaling pathway
hai04060  Cytokine-cytokine receptor interaction
hai04110  Cell cycle
hai04115  p53 signaling pathway
hai04151  PI3K-Akt signaling pathway
hai04310  Wnt signaling pathway
hai04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system